D.S. Pharmaceuticals Inc.

Biogen Idec's oral compound BG-12 achieves development milestones in MS and RA.
NewsRx Health; 12/27/2009; 988 words; ...Kate Dawson, M.D., senior director...regarding the compound's ability to reduce...Because of BG-12's unique effect on the...support the compound's evaluation in RA...Antirheumatic, Biogen Idec Inc., Biotechnology...Multiple Sclerosis, Pharmaceuticals, Relapsing-Remitting...

Second-line CML drugs evoke faster response than front-line therapy.
NewsRx Health & Science; 12/27/2009; 1324 words; ...Jorge Cortes, M.D., professor in M. D. Anderson's Leukemia Department...approved by the U.S. Food and Drug...Squibb Company Inc., Cancer, Chronic...AG, Oncology, Pharmaceutical Business, Pharmaceutical...University of Texas M. D. Anderson Cancer...

Data on cardiovascular disease published by C. Kazda and colleagues.(Clinical report)
Heart Disease Weekly; 12/27/2009; 934 words; ...exenatide (5 mu g b.i.d. for 4 weeks then 10 mu g b.i.d.) or glimepiride...with mean (+/- s.d.) age 57.2...Blackwell Publishing, Inc., Commerce Place...Diabetes, Overweight, Pharmaceuticals, Pregnancy, Therapy...

Researchers from Korea University report recent findings in asia-pacific economics.
Economics Week; 12/25/2009; 941 words; ...large firms in R&D enterprises...firm size in the pharmaceutical and semiconductor...evidence in the pharmaceutical industry that this...firms organize R&D activities." Kim...The publisher's contact information...Blackwell Publishing, Inc., Commerce Place...Life Sciences, ...

Data from University of Heidelberg advance knowledge in kidneys.
Angiogenesis Weekly; 12/25/2009; 785 words; ...Intervent Radiol, INF 110, D-69120 Heidelberg, Germany. The publisher's contact information for the...Urology is: Elsevier Science Inc., 360 Park Avenue South...Nephrology, Oncology, Pharmaceuticals, Renal Artery, Therapy...